Biogen Inc (NASDAQ:BIIB) - Share price - Overview


Stock Report

Biogen Inc BIIB

Last Price
$216.71

Day Change
-10.17|-4.48%

As of 22/03/2019
19:59:18 EDT | USD
Minimum 15 Minutes Delay.

Last Close226.88
Day Range216.49 - 226.80
Mkt Cap42.63Bil
52-Wk Range216.49 - 388.67
Yield %-
ISINUS09062X1037
Volume8,490,852
P/E10.04
P/S3.31
P/CF7.19

Share Price

Financials
201620172018
More ...
Income Statement
Revenue11,448.8012,273.9013,452.90
Operating Income5,653.105,407.805,888.30
Net Income3,702.802,539.104,430.70
Basic EPS16.9611.9421.63
Avg. Diluted Shares Outstanding219213205
Balance Sheet
Current Assets8,732.207,873.307,640.90
Non Current Assets14,144.6015,779.3017,648.00
Total Assets22,876.8023,652.6025,288.90
Current Liabilities3,419.903,368.203,295.20
Total Liabilities10,748.2011,054.5012,257.30
Total Equity12,140.1012,612.8013,039.60
Cash Flow
Operating Cash Flow4,522.404,551.006,187.70
Capital Expenditure-727.70-1,962.80-886.10
Free Cash Flow3,794.702,588.205,301.60

In millions, except "Basic EPS". Currency is USD.

Company Profile

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

7,800
Key Stats
More ...
Price/Earning TTM10.49
Price/Book3.42
Price/Sales TTM3.46
Rev Growth (3 year avg)7.72
EPS Growth (3 year avg)-
Operating Margin % TTM43.77
Net Margin % TTM32.93
ROE TTM34.54
Debt/Equity0.46
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.